ArticleScientific reports2018

RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model.

Chae Eun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.